Optimization of regimes of mobilization of blood hemopoietic stem cells in patients with multiple myeloma
Olga S. Pokrovskaya, Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Т. В. Гапонова(Ministry of Health of the Russian Federation), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Е. М. Грецов, Nikolay Nikolaevich Kalinin(National Medical Research Center for Hematology), И. В. Алексеева(National Medical Research Center for Hematology), Mikhail Drokov(National Research Center for Hematology Russian Academy of Medical Sciences), Н Н Калинин, Evgeniy Mikhaylovich Gretsov(National Medical Research Center for Hematology), Е О Грибанова, Inna Vladimirovna Alekseeva(National Medical Research Center for Hematology), Valeriy Grigor'evich Savchenko(National Medical Research Center for Hematology), Tatyana Vladimirovna Gaponova(National Medical Research Center for Hematology), Е С Урнова, Evdokiya S. Urnova(Ministry of Health of the Russian Federation), G. A. Klyasova(Ministry of Health of the Russian Federation)
DOAJ (DOAJ: Directory of Open Access Journals)
July 1, 2011
Cited by 0
Related Papers
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
|Journal of Infection|2017|198
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59